• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单核细胞来源的树突状细胞的双重促炎和抗炎特性。

Dual Pro- and Anti-Inflammatory Features of Monocyte-Derived Dendritic Cells.

机构信息

Department of Microbiology, Haukeland University Hospital, Helse Bergen, Bergen, Norway.

Department of Clinical Science, University of Bergen, Bergen, Norway.

出版信息

Front Immunol. 2020 Mar 27;11:438. doi: 10.3389/fimmu.2020.00438. eCollection 2020.

DOI:10.3389/fimmu.2020.00438
PMID:32292402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7120039/
Abstract

The transcription factor β-catenin is able to induce tolerogenic/anti-inflammatory features in different types of dendritic cells (DCs). Monocyte-derived dendritic cells (moDCs) have been widely used in dendritic cell-based cancer therapy, but so far with limited clinical efficacy. We wanted to investigate the hypothesis that aberrant differentiation or induction of dual pro- and anti-inflammatory features may be β-catenin dependent in moDCs. β-catenin was detectable in both immature and lipopolysaccharide (LPS)-stimulated DCs. The β-catenin inhibitor ICG-001 dose-dependently increased the pro-inflammatory signature cytokine IL-12p70 and decreased the anti-inflammatory signature molecule IL-10. The β-catenin activator 6-bromoindirubin-3'-oxime (6-BIO) dose-dependently increased total and nuclear β-catenin, and this was associated with decreased IL-12p70, increased IL-10, and reduced surface expression of activation markers, such as CD80 and CD86, and increased expression of inhibitory markers, such as PD-L1. 6-BIO and ICG-001 competed dose-dependently regarding these features. Genome-wide mRNA expression analyses further underscored the dual development of pro- and anti-inflammatory features of LPS-matured moDCs and suggest a role for β-catenin inhibition in production of more potent therapeutic moDCs.

摘要

转录因子β-连环蛋白能够诱导不同类型树突状细胞(DCs)产生耐受/抗炎特征。单核细胞来源的树突状细胞(moDCs)已广泛用于基于树突状细胞的癌症治疗,但迄今为止疗效有限。我们希望研究这样一种假设,即在 moDCs 中,异常分化或诱导双重促炎和抗炎特征可能依赖于β-连环蛋白。β-连环蛋白在未成熟和脂多糖(LPS)刺激的 DCs 中均可检测到。β-连环蛋白抑制剂 ICG-001 呈剂量依赖性增加促炎特征细胞因子 IL-12p70,并降低抗炎特征分子 IL-10。β-连环蛋白激活剂 6-溴靛红-3'-肟(6-BIO)呈剂量依赖性增加总核β-连环蛋白,这与 IL-12p70 减少、IL-10 增加以及激活标志物(如 CD80 和 CD86)表面表达减少和抑制标志物(如 PD-L1)表达增加相关。6-BIO 和 ICG-001 关于这些特征呈剂量依赖性竞争。全基因组 mRNA 表达分析进一步强调了 LPS 成熟 moDCs 中促炎和抗炎特征的双重发展,并表明β-连环蛋白抑制在产生更有效的治疗性 moDCs 方面发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ce/7120039/5541d1bdf4c0/fimmu-11-00438-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ce/7120039/91c805f12675/fimmu-11-00438-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ce/7120039/f94955073e50/fimmu-11-00438-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ce/7120039/42f6685045b4/fimmu-11-00438-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ce/7120039/4d59613a2b5d/fimmu-11-00438-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ce/7120039/b374a48ec40e/fimmu-11-00438-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ce/7120039/5541d1bdf4c0/fimmu-11-00438-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ce/7120039/91c805f12675/fimmu-11-00438-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ce/7120039/f94955073e50/fimmu-11-00438-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ce/7120039/42f6685045b4/fimmu-11-00438-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ce/7120039/4d59613a2b5d/fimmu-11-00438-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ce/7120039/b374a48ec40e/fimmu-11-00438-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27ce/7120039/5541d1bdf4c0/fimmu-11-00438-g0006.jpg

相似文献

1
Dual Pro- and Anti-Inflammatory Features of Monocyte-Derived Dendritic Cells.单核细胞来源的树突状细胞的双重促炎和抗炎特性。
Front Immunol. 2020 Mar 27;11:438. doi: 10.3389/fimmu.2020.00438. eCollection 2020.
2
The Complement Inhibitor Factor H Generates an Anti-Inflammatory and Tolerogenic State in Monocyte-Derived Dendritic Cells.补体抑制因子H在单核细胞衍生的树突状细胞中产生抗炎和致耐受性状态。
J Immunol. 2016 May 15;196(10):4274-90. doi: 10.4049/jimmunol.1500455. Epub 2016 Apr 13.
3
Modulatory effect of rapamycin and tacrolimus on monocyte-derived dendritic cells phenotype and function.雷帕霉素和他克莫司对单核细胞来源树突状细胞表型和功能的调节作用。
Immunobiology. 2021 Jan;226(1):152031. doi: 10.1016/j.imbio.2020.152031. Epub 2020 Nov 23.
4
IL-4 blocks TH1-polarizing/inflammatory cytokine gene expression during monocyte-derived dendritic cell differentiation through histone hypoacetylation.白细胞介素-4 通过组蛋白低乙酰化阻断单核细胞来源树突状细胞分化过程中 TH1 极化/炎症细胞因子基因的表达。
J Allergy Clin Immunol. 2013 Dec;132(6):1409-19. doi: 10.1016/j.jaci.2013.08.039. Epub 2013 Oct 17.
5
Inhibitory effects of suplatast tosilate on the differentiation and function of monocyte-derived dendritic cells from patients with asthma.托西酸舒托必利对哮喘患者单核细胞来源树突状细胞分化及功能的抑制作用
Clin Exp Allergy. 2007 Jul;37(7):1083-9. doi: 10.1111/j.1365-2222.2006.02616.x.
6
LPS enhances CTB-INSULIN induction of IDO1 and IL-10 synthesis in human dendritic cells.脂多糖增强 CTB-INSULIN 诱导人树突状细胞中 IDO1 和 IL-10 的合成。
Cell Immunol. 2019 Apr;338:32-42. doi: 10.1016/j.cellimm.2019.03.003. Epub 2019 Mar 19.
7
Alteration in the production of IL-10 and IL-12 and aberrant expression of CD23, CD83 and CD86 by monocytes or monocyte-derived dendritic cells from atopic dermatitis patients.特应性皮炎患者的单核细胞或单核细胞衍生的树突状细胞产生IL-10和IL-12的改变以及CD23、CD83和CD86的异常表达。
Exp Dermatol. 2003 Feb;12(1):86-95. doi: 10.1034/j.1600-0625.2003.120111.x.
8
Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.β干扰素增强B7-H1(程序性死亡配体1)在单核细胞和树突状细胞中的表达,B7-H1是自体T细胞活化的强效抑制剂:对多发性硬化症免疫调节作用的相关性。
J Neuroimmunol. 2004 Oct;155(1-2):172-82. doi: 10.1016/j.jneuroim.2004.06.013.
9
Dendritic Cells Differentiated from Human Umbilical Cord Blood-Derived Monocytes Exhibit Tolerogenic Characteristics.源自人脐带血单核细胞的树突状细胞具有致耐受性特征。
Stem Cells Dev. 2015 Dec 1;24(23):2796-807. doi: 10.1089/scd.2014.0600. Epub 2015 Sep 1.
10
Interleukin 35: Inhibitory regulator in monocyte-derived dendritic cell maturation and activation.白细胞介素 35:单核细胞来源的树突状细胞成熟和激活的抑制调节因子。
Cytokine. 2018 Aug;108:43-52. doi: 10.1016/j.cyto.2018.03.008. Epub 2018 Mar 20.

引用本文的文献

1
Ginsenoside Rb1 attenuates neuroflammation via activating Wnt/β-catenin signaling pathway to exert neuroprotective effect on cerebral ischemic-reperfusion injury.人参皂苷Rb1通过激活Wnt/β-连环蛋白信号通路减轻神经炎症,对脑缺血再灌注损伤发挥神经保护作用。
Front Aging Neurosci. 2025 Aug 6;17:1555067. doi: 10.3389/fnagi.2025.1555067. eCollection 2025.
2
LRH-1/NR5A2 targets mitochondrial dynamics to reprogram type 1 diabetes macrophages and dendritic cells into an immune tolerance phenotype.肝受体同源物-1/核受体5A2靶向线粒体动力学,将1型糖尿病巨噬细胞和树突状细胞重编程为免疫耐受表型。
Clin Transl Med. 2024 Dec;14(12):e70134. doi: 10.1002/ctm2.70134.
3

本文引用的文献

1
Pharmacological inhibition of β-catenin/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating T cells.β-连环蛋白/BCL9 相互作用的药理学抑制通过调节 T 细胞克服免疫检查点阻断的耐药性。
Sci Adv. 2019 May 8;5(5):eaau5240. doi: 10.1126/sciadv.aau5240. eCollection 2019 May.
2
An Update on Anti-CD137 Antibodies in Immunotherapies for Cancer.抗 CD137 抗体在癌症免疫治疗中的最新进展。
Int J Mol Sci. 2019 Apr 12;20(8):1822. doi: 10.3390/ijms20081822.
3
The clinical application of cancer immunotherapy based on naturally circulating dendritic cells.
The Potential of Anti-Inflammatory DC Immunotherapy in Improving Proteinuria in Type 2 Diabetes Mellitus.
抗炎性树突状细胞免疫疗法改善2型糖尿病蛋白尿的潜力
Vaccines (Basel). 2024 Aug 27;12(9):972. doi: 10.3390/vaccines12090972.
4
Impaired Proliferation of CD8 T Cells Stimulated with Monocyte-Derived Dendritic Cells Previously Matured with Thapsigargin-Stimulated LAD2 Human Mast Cells.经 Thapsigargin 刺激的 LAD2 人肥大细胞预先成熟的单核细胞来源树突状细胞刺激的 CD8 T 细胞增殖受损。
J Immunol Res. 2024 Jul 18;2024:5537948. doi: 10.1155/2024/5537948. eCollection 2024.
5
Cellular interactions in tumor microenvironment during breast cancer progression: new frontiers and implications for novel therapeutics.在乳腺癌进展过程中肿瘤微环境中的细胞相互作用:新前沿及其对新型治疗的意义。
Front Immunol. 2024 Mar 12;15:1302587. doi: 10.3389/fimmu.2024.1302587. eCollection 2024.
6
Dendritic cells: the yin and yang in disease progression.树突状细胞:疾病进展中的阴阳。
Front Immunol. 2024 Jan 4;14:1321051. doi: 10.3389/fimmu.2023.1321051. eCollection 2023.
7
The CD40 agonist HERA-CD40L results in enhanced activation of antigen presenting cells, promoting an anti-tumor effect alone and in combination with radiotherapy.CD40 激动剂 HERA-CD40L 可增强抗原呈递细胞的激活,单独使用和与放射治疗联合使用均可发挥抗肿瘤作用。
Front Immunol. 2023 May 26;14:1160116. doi: 10.3389/fimmu.2023.1160116. eCollection 2023.
8
GM-CSF, Flt3-L and IL-4 affect viability and function of conventional dendritic cell types 1 and 2.GM-CSF、Flt3-L 和 IL-4 影响常规树突状细胞 1 型和 2 型的活力和功能。
Front Immunol. 2023 Jan 12;13:1058963. doi: 10.3389/fimmu.2022.1058963. eCollection 2022.
9
The effects of dendritic cell-based vaccines in the tumor microenvironment: Impact on myeloid-derived suppressor cells.基于树突状细胞的疫苗在肿瘤微环境中的作用:对髓系来源的抑制细胞的影响。
Front Immunol. 2022 Nov 15;13:1050484. doi: 10.3389/fimmu.2022.1050484. eCollection 2022.
10
Pharmacological suppression of glycogen synthase kinase-3 reactivates HIV-1 from latency via activating Wnt/β-catenin/TCF1 axis in CD4 T cells.通过激活 CD4 T 细胞中的 Wnt/β-catenin/TCF1 轴,抑制糖原合酶激酶-3 的药理学作用可使潜伏状态的 HIV-1 重新激活。
Emerg Microbes Infect. 2022 Dec;11(1):391-405. doi: 10.1080/22221751.2022.2026198.
基于自然循环树突状细胞的癌症免疫疗法的临床应用。
J Immunother Cancer. 2019 Apr 18;7(1):109. doi: 10.1186/s40425-019-0580-6.
4
Immunomodulatory Bonds of the Partnership between Dendritic Cells and T Cells.树突状细胞与T细胞之间伙伴关系的免疫调节联系
Crit Rev Immunol. 2018;38(5):379-401. doi: 10.1615/CritRevImmunol.2018026790.
5
WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers.WNT/β-catenin 通路激活与人类癌症中的免疫排斥相关。
Clin Cancer Res. 2019 May 15;25(10):3074-3083. doi: 10.1158/1078-0432.CCR-18-1942. Epub 2019 Jan 11.
6
Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment.树突状细胞与肿瘤微环境中的 CD8 T 细胞免疫
Front Immunol. 2018 Dec 20;9:3059. doi: 10.3389/fimmu.2018.03059. eCollection 2018.
7
WNT Signaling in Cancer Immunosurveillance.WNT 信号通路在癌症免疫监视中的作用。
Trends Cell Biol. 2019 Jan;29(1):44-65. doi: 10.1016/j.tcb.2018.08.005. Epub 2018 Sep 13.
8
Towards superior dendritic-cell vaccines for cancer therapy.迈向用于癌症治疗的优质树突状细胞疫苗。
Nat Biomed Eng. 2018 Jun;2(6):341-346. doi: 10.1038/s41551-018-0250-x. Epub 2018 Jun 11.
9
Wnt signalling: conquering complexity.Wnt 信号通路:征服复杂性。
Development. 2018 Jun 26;145(12):dev165902. doi: 10.1242/dev.165902.
10
Targeting VEGF/VEGFR to Modulate Antitumor Immunity.针对 VEGF/VEGFR 调节抗肿瘤免疫。
Front Immunol. 2018 May 3;9:978. doi: 10.3389/fimmu.2018.00978. eCollection 2018.